Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9F4Y

UP1 in complex with Z90120418

Summary for 9F4Y
Entry DOI10.2210/pdb9f4y/pdb
DescriptorHeterogeneous nuclear ribonucleoprotein A1, N-terminally processed, 1-(3,4,5-trimethoxyphenyl)methanamine (3 entities in total)
Functional Keywordsfragment screening, hnrnp a1, up1, rna/dna binding protein, up1-fragment complex, rna binding protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight22554.34
Authors
Dunnett, L.,Prischi, F. (deposition date: 2024-04-28, release date: 2024-05-08, Last modification date: 2025-04-02)
Primary citationDunnett, L.,Das, S.,Venditti, V.,Prischi, F.
Enhanced identification of small molecules binding to hnRNPA1 via cryptic pockets mapping coupled with X-ray fragment screening.
J.Biol.Chem., 301:108335-108335, 2025
Cited by
PubMed Abstract: The human heterogeneous nuclear ribonucleoprotein (hnRNP) A1 is a prototypical RNA-binding protein essential for regulating a wide range of post-transcriptional events in cells. As a multifunctional protein with a key role in RNA metabolism, deregulation of its functions has been linked to neurodegenerative diseases, tumor aggressiveness, and chemoresistance, which has fuelled efforts to develop novel therapeutics that modulate its RNA-binding activities. Here, using a combination of molecular dynamics simulations and graph neural network pocket predictions, we showed that hnRNPA1 N-terminal RNA-binding domain (unwinding protein 1 [UP1]) contains several cryptic pockets capable of binding small molecules. To identify chemical entities for the development of potent drug candidates and experimentally validate identified druggable hotspots, we carried out a large fragment screening on UP1 protein crystals. Our screen identified 36 hits that extensively sample UP1 functional regions involved in RNA recognition and binding as well as map hotspots onto novel protein interaction surfaces. We observed a wide range of ligand-induced conformational variation by stabilization of dynamic protein regions. Our high-resolution structures, the first of an hnRNP in complex with a fragment or small molecule, provide rapid routes for the rational development of a range of different inhibitors and chemical tools for studying molecular mechanisms of hnRNPA1-mediated splicing regulation.
PubMed: 39984046
DOI: 10.1016/j.jbc.2025.108335
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.4 Å)
Structure validation

234785

数据于2025-04-16公开中

PDB statisticsPDBj update infoContact PDBjnumon